J. Goldman & Co’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Hold
0
463
2024
Q4
Hold
0
468
2024
Q3
Hold
0
465
2024
Q2
Hold
0
443